BE494334A - - Google Patents
Info
- Publication number
- BE494334A BE494334A BE494334DA BE494334A BE 494334 A BE494334 A BE 494334A BE 494334D A BE494334D A BE 494334DA BE 494334 A BE494334 A BE 494334A
- Authority
- BE
- Belgium
- Prior art keywords
- penicillin
- solution
- quinine
- salt
- propylene glycol
- Prior art date
Links
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 18
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 claims description 16
- LOUPRKONTZGTKE-WZBLMQSHSA-N Quinine Chemical class C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-WZBLMQSHSA-N 0.000 claims description 15
- 229930182555 Penicillin Natural products 0.000 claims description 14
- 229940049954 penicillin Drugs 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 8
- 239000002904 solvent Substances 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical group [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 claims description 2
- 239000000243 solution Substances 0.000 description 11
- 238000002360 preparation method Methods 0.000 description 7
- 235000001258 Cinchona calisaya Nutrition 0.000 description 6
- LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 description 6
- 229960000948 quinine Drugs 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 229930013930 alkaloid Natural products 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- -1 butyl para-amino-benzoate Chemical compound 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 150000002960 penicillins Chemical class 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- LKUVXQMSYPYURB-DSXUQNDKSA-N (r)-[(2s,4s,5r)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol;formic acid Chemical compound OC=O.C([C@H]([C@H](C1)C=C)C2)CN1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 LKUVXQMSYPYURB-DSXUQNDKSA-N 0.000 description 1
- 150000001447 alkali salts Chemical class 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 239000003708 ampul Substances 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000000887 hydrating effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229940056360 penicillin g Drugs 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE494334A true BE494334A (https=) |
Family
ID=138111
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE494334D BE494334A (https=) |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE494334A (https=) |
-
0
- BE BE494334D patent/BE494334A/fr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1203242A (fr) | Procede de preparation de sels derives de l'acide 3- hydroxybutanoique et d'une base organique aminee, et les sels ainsi obtenus | |
| EP0671912B1 (fr) | Compositions injectables a base de derives des taxanes | |
| CH646412A5 (fr) | Procede de preparation des produits hydrosolubles a base de (+)-catechine et compositions contenant ces produits. | |
| KR840001212B1 (ko) | 3-알릴-7.8-디히드록시-6-할로-1-(4-히드록시페닐)-2,3,4,5-테트라히드로-1h-3-벤즈 아제핀 유도체의 제조방법 | |
| MC1651A1 (fr) | Gluconate de l'amino-2 ethoxycarbonylamino-3(fluoro-4 benzylamino)-6 pyridine et compositions pharmaceutiques renfermant ce compose | |
| CH670448A5 (https=) | ||
| BE494334A (https=) | ||
| WO1993005782A1 (fr) | Sels de sparfloxacine et solutions les contenant | |
| FR2540109A1 (fr) | Imino-2 pyrrolidines, leur procede de preparation et leurs applications en therapeutique | |
| KR840000702B1 (ko) | 빈카민 사카리네이트의 제조방법 | |
| Einstein et al. | Separation of vasodilator and negative chronotropic actions in analogues of adenosine | |
| BE1001704A3 (fr) | Compositions aqueuses contenant un derive de l'acide piperidinylcyclopentylheptenoique. | |
| CH605606A5 (https=) | ||
| CH637930A5 (fr) | Analogues de la prostaglandine i(2) et compositions pharmaceutiques les contenant. | |
| CH648302A5 (fr) | Lactates du 4'-(9-acridinylamino-methanesulf-m-anidiside, leur procede de production et composition pharmaceutique les contenant. | |
| FR2594439A1 (fr) | Nouveaux derives ester, thioester et amide de quinolone, leur procede de preparation et leur application en therapeutique | |
| EP0060182B1 (fr) | Thioalkylamide de l'acide nicotinique 1-oxyde, ses sels, procédé pour leur préparation et compositions pharmaceutiques | |
| FR2468373A1 (fr) | Solvant parenteral et procede de preparation de solutions stables qui les contiennent | |
| BE509486A (https=) | ||
| BE482618A (https=) | ||
| BE462012A (https=) | ||
| BE824052A (fr) | Nouveaux composes heterocycliques, leur preparation et leur application comme medicaments | |
| LU85212A1 (fr) | Nouveaux derives de l'acide lysergique,leur preparation et leur utilisation comme medicaments | |
| FR2540874A1 (fr) | Nouveaux derives de l'acide lysergique, leur preparation et leur utilisation comme medicaments | |
| SU116781A1 (ru) | Способ приготовлени водных растворов рутина дл парэнтерального введени |